Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Bartosz, Pula"'
Autor:
Joanna Zaleska, Paulina Kwasnik, Magdalena Paziewska, Joanna Purkot, Aleksandra Szabelak, Mateusz Jurek, Natalia Masny, Izabela Dziatkiewicz, Bartosz Pronobis‐Szczylik, Agnieszka Piebiak, Agnieszka Szymczyk, Katarzyna Jarosz‐Chudzik, Lukasz Bolkun, Katarzyna Kozlowska, Jaroslaw Piszcz, Edyta Subocz, Janusz Halka, Michal Bator, Elzbieta Kalicinska, Tomasz Wrobel, Lidia Usnarska‐Zubkiewicz, Justyna Rybka, Izabela Deren‐Wagemann, Marta Szyca‐Smieszniak, Jaroslaw Dybko, Iwona Hus, Bartosz Pula, Edyta Cichocka, Marcin Rymko, Dorota Zdunczyk, Mateusz Ziarkiewicz, Grzegorz Wladyslaw Basak, Lars Bullinger, Krzysztof Giannopoulos
Publikováno v:
International Journal of Cancer. 152:705-712
Multiple myeloma (MM) and chronic lymphocytic leukemia (CLL) patients have increased morbidity and mortality rates of COVID-19 due to immunosuppression associated with the disease and ongoing therapy. The same immune impairment accompanying CLL and M
Autor:
Łukasz Bołkun, Bartosz Pula, Agnieszka Kołkowska‐Leśniak, Marta Morawska, Edyta Cichocka, Grzegorz Charlinski, Bartosz Garus, Sebastian Giebel, Jaroslaw Piszcz, Joanna Drozd‐Sokolowska, Jacek Kwiatkowski, Monika Biernat, Iwona Hus, Ewa Lech‐Maranda, Monika Długosz‐Danecka, Krzysztof Giannopoulos, Tomasz Wróbel
Publikováno v:
International Journal of Cancer.
Autor:
Kristyna Kupcova, Joanna Barankiewicz, Bjoern Chapuy, Anna Szumera-Ciećkiewicz, Anna Polak, Magdalena Winiarska, Joanna Domagala, Dorota Komar, Bartosz Pula, Magdalena Cybulska, Agnieszka Graczyk-Jarzynka, Ewa Jabłońska, Dominika Nowis, Michal Mikula, Michael R. Green, Krzysztof Brzózka, Michał Pawlak, Beata Pyrzynska, Filip Garbicz, Andrea Massimiliano Tomirotti, Malgorzata Statkiewicz, Monika Prochorec-Sobieszek, Kamil Bojarczuk, Aniela Golas, Ondrej Havranek, Jakub Golab, Marta Gajewska, Patryk Górniak, Maciej Szydlowski, Mariana Pacheco-Blanco, Emilia Bialopiotrowicz, Grzegorz Rymkiewicz, Przemyslaw Juszczynski
Publikováno v:
Cancer Research. 81:6029-6043
The family of PIM serine/threonine kinases includes three highly conserved oncogenes, PIM1, PIM2, and PIM3, which regulate multiple prosurvival pathways and cooperate with other oncogenes such as MYC. Recent genomic CRISPR-Cas9 screens further highli
Autor:
Karolina Jablonska, Bartosz Pula, Agata Zemla, Christopher Kobierzycki, Witold Kedzia, Ewa Nowak-Markwitz, Marek Spaczynski, Maciej Zabel, Marzenna Podhorska-Okolow, Piotr Dziegiel
Publikováno v:
International Journal of Molecular Sciences, Vol 15, Iss 12, Pp 23074-23089 (2014)
Ovarian cancer (OC) is the leading cause of death among women with genital tract disorders. Melatonin exhibits oncostatic properties which it may effect through binding to its membrane receptor, MT1. The aim of this study was to determine the express
Externí odkaz:
https://doaj.org/article/1092252be42a42d78b344d5789642438
Autor:
Bartosz Pula, Ewa Bodzenta, Dorota Zdunczyk, Małgorzata Rydzanicz, Iwona Sokolowska-Giezgala, Katarzyna Warzybok, Marcin M Machnicki, Magdalena Olszewska-Szopa, Anna Labedz, Jolanta Wieczorek, Dominika Wisniewska-Organek, Tomasz Stoklosa, Kamila Kruczkowska-Tarantowicz, Krzysztof Jamroziak, Marek Dudziński, Zofia Spyra-Gorny, Rafał Płoski, Dariusz Kumorek, Monika Pepek, Alina Urbanowicz, Elzbieta Morawiec-Szymonik, Agnieszka Szeremet, Pawel Bernatowicz, Agnieszka Pollak, Ryszard Wichary, Waldemar Tomczak
Publikováno v:
Acta Haematologica Polonica. 52:94-102
Indtroduction and methods: In chronic lymphocytic leukemia (CLL), molecular and cytogenetic diagnostics are crucial for the determination of accurate prognosis and treatment choice. Among different genetic aberrations, del(17p13) or TP53 mutations co
Autor:
Bartosz Pula, Tomasz Stoklosa, Joanna Mańko, Monika Pepek, Kazimierz Hałaburda, Iwona Hus, Ewa Lech-Marańda
Publikováno v:
Hematologia. 11:95-100
Chronic lymphocytic leukemia (CLL) is the most common diagnosed leukemia in adults. Its clinical course is very heterogenous and only allogeneic hematopoietic stem cell transplantation (allo-HSCT) ensures cure of this disease. Introduction of venetoc
Autor:
Krzysztof Jamroziak, Joanna Knap, Kamil Wiśniewski, Anna Waszczuk-Gajda, Edyta Subocz, Marek Hus, Marta Kaźmierczak, Bartosz Pula, Anna Łabędź, Kamil Wdowiak, Sebastian Grosicki, Marta Masternak, Krzysztof Giannopoulos, Agnieszka Szymczyk, Joanna Drozd-Sokołowska, Łukasz Szukalski, Janusz Hałka, Izabela Kozłowska
Publikováno v:
Cancer Management and Research. 12:9977-9985
Purpose Mean platelet volume (MPV) is a readily accessible and commonly tested hematological indicator. Recent studies revealed a significant impact of MPV on the course and prognosis of many diseases, including some types of cancer, as well as on th
Autor:
Andrzej Bieniek, Bartosz Pula, Aleksandra Piotrowska, Marzena Podhorska-Okolow, Anna Salwa, Maria Koziol, Piotr Dziegiel
Publikováno v:
Folia Histochemica et Cytobiologica, Vol 50, Iss 3, Pp 352-357 (2012)
Basal cell carcinoma (BCC) is the most frequent skin cancer, with many different histological subtypes.Recent studies have investigated the expression of proliferative markers, but little is known about theexpression of metallothioneins (MT) in diffe
Externí odkaz:
https://doaj.org/article/709e14e0a6684c8b8875d2ffa7bb9f7f
Autor:
Waldemar Sawicki, Artur Jurczyszyn, Kazimierz Hałaburda, Krzysztof Jamroziak, Grzegorz Helbig, Piotr Boguradzki, Malgorzata Sobczyk-Kruszelnicka, Sonia Dębek, Jarosław Dybko, Lidia Gil, Aleksandra Gołos, Bartosz Pula, Krzysztof Warzocha
Publikováno v:
Advances in Medical Sciences. 65:429-436
Purpose In this multicenter retrospective analysis of the Polish Myeloma Group we assessed the real-life application of allogeneic transplantations (alloHCT) in multiple myeloma (MM) outside clinical trials in Poland. Methods Anonymized clinical data
Autor:
Marek Dudziński, Monika Długosz-Danecka, Małgorzata Wojciechowska, Michal Osowiecki, Elżbieta Iskierka-Jażdżewska, Weronika Piszczek, Jan Maciej Zaucha, Agnieszka Szymczyk, Edyta Subocz, Joanna Drozd-Sokołowska, Anna Waszczuk-Gajda, Beata Kumiega, Krzysztof Giannopoulos, Ryszard Wichary, Marek Hus, Bartosz Pula, Wojciech Jurczak, Tadeusz Robak, Bożena Katarzyna Budziszewska, Janusz Hałka, Wanda Knopinska-Posluszny, Krzysztof Jamroziak, Agnieszka Szeremet, Andrzej Pluta, Daria Zawirska, Paweł Steckiewicz, Jadwiga Hołojda, Ewa Lech-Marańda
Publikováno v:
Anticancer Research. 40:4059-4066
Background/aim To study the long-term clinical efficacy and tolerability of ibrutinib monotherapy in real-world relapsed and refractory chronic lymphocytic leukemia (RR-CLL) patients outside clinical trials. Patients and methods Clinical data of 171